Fusion protein technologies for biopharmaceuticals : applications and challenges /
The state of the art in biopharmaceutical FUSION PROTEIN DESIGN Fusion proteins belong to the most lucrative biotech drugs-with Enbrel® being one of the best-selling biologics worldwide. Enbrel® represents a milestone of modern therapies just as Humulin®, the first therapeutic recombinant protein fo...
Άλλοι συγγραφείς: | |
---|---|
Μορφή: | Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Hoboken, New Jersey :
John Wiley & Sons,
[2013]
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |